ArticleJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs2026
Case-specific optimal extracorporeal membrane oxygenation configuration for cardiogenic shock in the peripartum period: a case report.
Article in Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For pregnant patients with severe coronavirus disease 2019 (COVID-19) requiring veno-venous (V-V) extracorporeal membrane oxygenation (ECMO), the ideal timing of delivery is uncertain, particularly when complicated by cardiogenic shock. A 44-year-old patient experienced severe respiratory failure due to COVID-19 at 23 weeks of gestation and underwent V-V ECMO support. Due to severely depressed biventricular cardiac function caused by Staphylococcus aureus bacteremia, the ECMO mode was converted from V-V to veno-arteriovenous (V-AV) ECMO, resulting in improved maternal cardiac function and fetal oxygen supply. At 27 weeks of gestation, she had an unexpected premature rupture of membranes and precipitous vaginal delivery. Despite several complications, she was successfully rehabilitated and discharged after 104 days of ECMO support. Appropriate ECMO implementation, including mode application, together with meticulous multidiscipline discussion on the optimal timing of delivery and prompt decision-making in the event of an unexpected delivery, is critical for maternal and fetal health.
Indexed as
Identifiers
41649588What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.